Results 101 to 110 of about 27,793 (201)
OBJECTIVES: To determine the HIV vertical transmission rate (VTR) and associated risk factors by use of zidovudine and infant care education in Brazil.
Nogueira Susie A. +12 more
doaj
Zidovudine-induced reversible pure red cell aplasia
Hematological abnormalities are frequent among human immunodeficiency virus (HIV)-infected patients and may be directly attributable to the virus or may be caused by opportunistic infections, neoplasms or drugs that cause bone marrow suppression or ...
Balakrishnan, Anuja +5 more
core
OBJECTIVE--To determine the association between elapsed time since starting zidovudine and survival in patients with acquired immunodeficiency syndrome (AIDS).
Phillips, A N +8 more
core +1 more source
Quinazoline-tethered thiazolo[3,2-<i>a</i>]pyrimidines and their cyclic chalcone derivatives as HIV-1 reverse transcriptase inhibitors: green synthesis, molecular docking, and <i>in silico</i> studies. [PDF]
Gomha SM +7 more
europepmc +1 more source
ZIDOVUDINE: A TARGETED THERAPY FOR ENDEMIC BURKITT'S LYMPHOMA
Background: Although cyclophosphamide based regimens can produce remission rates approaching 60 to 80% in endemic Burkitts lymphoma, relapses and refractory disease are fairly common in developing countries, due to advanced stage disease and ...
HARRINGTON, W.J. +4 more
core
Physiologically based pharmacokinetic modeling of fluconazole: interpretation of gender-dependent pharmacokinetics and cytochrome P450 inhibition. [PDF]
Ishida K, Tanna RS, Yang J, Lai Y.
europepmc +1 more source
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O +3 more
doaj
Neonatal HIV prophylaxis is associated with accelerated presentation and clinical progression of MPV17-related mitochondrial neurohepatopathy. [PDF]
Rose PC +8 more
europepmc +1 more source

